Collaboration between cardiologist and clinical pharmacist on prescription quality: What is the potential clinical impact for cardiology patients?
Open Access
- 27 May 2020
- journal article
- research article
- Published by Hindawi Limited in International Journal of Clinical Practice
- Vol. 74 (9), e13531
- https://doi.org/10.1111/ijcp.13531
Abstract
Objectives The aim of this study was to determine the effect of pharmacists’ interventions (PI) on the potential clinical impact of medication errors, including the lack of therapeutic optimisation of patients with cardiologic diseases, such as heart failure and acute coronary syndrome). Methods This was an observational, prospective study conducted in the cardiology department of a French university hospital centre for a duration of 9 months. All prescriptions were analysed and PI were registered for clinical rating by pharmacists and cardiologist. Results A total of 532 PI cases were recorded in 339 patients, with a mean of 1.57 (±1.04) PI. The PI acceptance rate was 98.1%. “Dose adjustment” and “introduction therapy” were the most common interventions and represented 38.0% and 32.9%, respectively, of all PI. Statins were the most frequently involved drugs (18.1%), followed by ACE (Angiotensin Converting Enzyme) inhibitors (10.9%) and antiplatelet agents (9.3%). Moreover, 13.8% of PI potentially avoided a severe or very severe clinical impact (n = 71) and 38.6% had a significant impact altering the quality of life (n = 198). There was no significant difference between the average score performed by the clinical pharmacist included in the cardiology team and the one obtained by the cardiologist (P = .797). In contrast, a significant difference was observed for the average score established by the pharmacist localised in central pharmacy versus the rating of the cardiologist (P < .001). Conclusions The collaboration between clinical pharmacists and cardiologists in the medical units seems to be beneficial to the quality of prescriptions, including the implementation of recommendations. The good rate of PI acceptance and the similar rating with the cardiologist show that there is a change in perspective of the pharmacist, being closer to the clinical reality.Keywords
This publication has 24 references indexed in Scilit:
- 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failureEuropean Heart Journal, 2016
- 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failureEuropean Journal of Heart Failure, 2016
- Clinical-pharmacist intervention reduces clinically relevant drug–drug interactions in patients with heart failure: A randomized, double-blind, controlled trialInternational Journal of Cardiology, 2016
- Impact of a Multidisciplinary Heart Failure Post-hospitalization Program on Heart Failure Readmission RatesAnnals of Pharmacotherapy, 2015
- Medication Reconciliation in Patients Hospitalized in a Cardiology UnitPLOS ONE, 2014
- Discharge Counseling for Patients with Heart Failure or Myocardial Infarction: A Best Practices Model Developed by Members of the American College of Clinical Pharmacy's Cardiology Practice and Research Network Based on the Hospital to Home (H2H) InitiativePharmacotherapy: The Journal of Human Pharmacology and Drug Therapy, 2013
- The impact of pharmacist-initiated interventions in improving acute coronary syndrome secondary prevention pharmacotherapy prescribing upon dischargeJournal of Clinical Pharmacy & Therapeutics, 2013
- Optimization of heart FailUre medical Treatment after hospital discharge according to left ventricUlaR Ejection fraction: The FUTURE surveyArchives of Cardiovascular Diseases, 2012
- The effect of a clinical pharmacist discharge service on medication discrepancies in patients with heart failurePharmacy World & Science, 2010
- Randomized clinical trial of a postdischarge pharmaceutical care program vs. regular follow-up in patients with heart failureFarmacia Hospitalaria, 2006